SLC6A2 and attention deficit-hyperactivity disorder: In the case of atomoxetine, significant correlation was found between the response status in childhood ADHD and DBH and SLC6A2 in a Chinese sample, and later in a broader sample (Yang et al., 2013; Fang et al., 2015; Gul et al., 2021).